> Products > CAS NO 352-32-9

China CAS NO 352-32-9 Factory

As a way to present you with ease and enlarge our enterprise, we also have inspectors in QC Workforce and assure you our greatest support and solution for CAS NO 352-32-9,352-32-9,p-Fluorotoluene, Our main objectives are to deliver our clients worldwide with good quality, competitive cost, happy delivery and superb providers.
CAS NO 352-32-9, We hope to have long-term cooperation relationships with our clients. If you are interested in any of our items, be sure to do not hesitate to send enquiry to us/company name. We ensure that you can be totally satisfied with our best solutions!

Hot Products

Perfluorotributylamine
Product Name:Perfluorotributylamine
Molecular Formula:C12F27N
Molecular Weight:671.09
CAS Registry Number:311-89-7
DMT-dC(Ac)-CE
Product Name:DMT-dC(Ac)-CE
Molecular Formula:C41H50N5O8P
Molecular Weight:771.84
CAS Registry Number:154110-40-4
5-{4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl}-2-imino-4-thiazolidinone
Product Name:5-{4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl}-2-imino-4-thiazolidinone
Molecular Formula:C19H21N3O2S
Molecular Weight:355.45
CAS Registry Number:105355-26-8
Fluconazole
Product Name:Fluconazole
Molecular Formula:C13H12F2N6O
Molecular Weight:306.27
CAS Registry Number:86386-73-4
2'-Deoxyguanosine monohydrate
Product Name:2'-Deoxyguanosine monohydrate
Molecular Formula:C10H15N5O5
Molecular Weight:285.26
CAS Registry Number:312693-72-4
(4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate
Product Name:(4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate
Molecular Formula:C12H14ClN3O2
Molecular Weight:267.71
CAS Registry Number:1146629-75-5

Related Blog
Reviews

Development Trend of China's Pharmaceutical Intermediate Industry
The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.
Bosutinib CAS 380843-75-4
Chemical name:4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile
How is a drug produced?
There are so many different drugs ,with different color /shape ( like capsule ,tablet or Infusion) and price . Here we would like to explain , what makes it so different? How is a drug produced?
What is an Active Pharmaceutical Ingredient (API in Pharma)?
Sandoo Pharmaceutical is a professional active pharmaceutical intermediate manufacturer, producing high quality APIs. Sandoo Pharmaceutical provides a wide range of active pharmaceutical intermediates.
FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC
On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.
Gilteritinib Fumarate
Sandoo Pharmaceutica is a professional pharmaceutical intermediates manufacturer. We provide good quality Gilteritinib Fumarate Cas: 1254053-43-4. Welcome and we look forward to your inquiry!

China CAS NO 352-32-9 Factory

Related Products

Hot Products

Perfluorotributylamine

DMT-dC(Ac)-CE

5-{4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl}-2-imino-4-thiazolidinone

Fluconazole

2'-Deoxyguanosine monohydrate

(4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate

Development Trend of China's Pharmaceutical Intermediate Industry

Bosutinib CAS 380843-75-4

How is a drug produced?

What is an Active Pharmaceutical Ingredient (API in Pharma)?

FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

Gilteritinib Fumarate

Ella 2022-08-05 01:34:23

Kim 2024-04-01 14:36:09

Myra 2023-10-18 00:24:56

Mandy 2024-05-24 23:30:35

Freda 2023-02-21 23:31:39

Aurora 2022-12-16 06:43:03

Send Inquiry